多家庭治疗与系统性单家庭治疗对年轻神经性厌食症患者疗效比较的多中心随机对照试验:THERAFAMBEST 研究方案
本研究为多中心随机对照试验,计划纳入150例符合入组标准的青少年神经性厌食症患者,随机分配至多家庭治疗(MFT)组或系统性单家庭治疗(SFT)组,两组均接受为期12个月的10次治疗。主要评估治疗开始后12个月和18个月时体重指数等临床结局的变化,并进行成本效益分析。研究假设MFT疗效不劣于SFT且成本更低。
要点
- 国际指南推荐涉及患者及其家庭的单家庭治疗用于青少年神经性厌食症。
- 多家庭治疗将多个患有相同疾病孩子的家庭聚集在一起进行干预。
- 本研究旨在评估MFT在体重指数等结局上是否不劣于SFT,并进行成本效益分析。
核心结论
- 研究假设MFT疗效不劣于SFT,但成本更低。
- 识别每种技术可能的优先适应症可帮助改善青少年神经性厌食症的治疗指征并促进早期干预,早期干预与更好结局相关。
研究设计与样本
- 多中心随机对照试验,计划纳入150例符合入组标准的患者,随机分配至MFT组或SFT组。
- 患者及其家庭接受为期12个月的10次治疗。
- 在治疗期间及18个月随访时评估体重、进食障碍及其他精神病理相关症状、家庭关系质量和家庭治疗满意度,并进行成本效益分析。
关键数值与推荐
- 国际指南推荐涉及患者及其家庭的单家庭治疗用于青少年神经性厌食症。
- MFT由多个患有相同疾病孩子的家庭聚集组成。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Anorexia nervosa (AN) is a serious psychiatric illness that begins most of the time during adolescence. An early and efficacious intervention is crucial to minimize the risk of the illness becoming chronic and to limit the occurrence of comorbidities. There is a global consensus on optimal treatment for adolescents suffering from AN: international guidelines recommend single-family therapy that involves the patient and his/her family. Several family therapy approaches have been developed to date. However, these approaches, which imply a direct questioning of intrafamilial dynamics, are not suitable for all patients and families, and the rates of dropout or poor response to treatment remain quite high. A modality of family therapy has been adapted to AN, known as multi-family therapy (MFT), which consists in bringing together several families whose children suffers from the same illness. Objectives of the present randomized clinical trial are to evaluate whether the implementation of MFT in a multi-disciplinary treatment program for adolescents with AN is at least as efficacious as the use of systemic single-family therapy (SFT), with respect to the evolution of body mass index and other clinical outcomes 12 and 18 months after the start of treatment. A cost-efficiency analysis will also be conducted. METHODS: One hundred fifty patients meeting the inclusion criteria will be randomly assigned to one of the two treatment groups. Patients and their families will receive 10 sessions of therapy spread over 12 months. Body weight, eating disorder and other psychopathology-related symptoms, quality of family relationships, and family satisfaction with treatment will be evaluated during the treatment and at an 18 months follow-up. A cost-efficiency analysis will also be carried out. DISCUSSION: We hypothesize that MFT is at least as efficacious as SFT, but at a lesser cost. The identification of possible preferential indications for each technique could help the improvement of therapeutic indications for adolescents suffering from AN and contribute to the earliness of intervention, which is associated with a better outcome. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03350594 . Registered on 22 November 2017. IDRCB number 2016-A00818-43.
引用
- Carrot B, Duclos J, Barry C, et al. Multicenter randomized controlled trial on the comparison of multi-family therapy (MFT) and systemic single-family therapy (SFT) in young patients with anorexia nervosa: study protocol of the THERAFAMBEST study. Trials. 2019. PMID: 31039797. doi:10.1186/s13063-019-3347-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。